Ledger.Open graph →
SEC Form D · filed November 28, 2018

Coeptis Pharmaceuticals, Inc

Offering
$18.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEXFORD, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dan Yerace · Wexford, PAExec · DirectorDavid Mehalick · Wexford, PAExec · Director · PromoterAlison C. Lawton · NEEDHAM, MAExec · Director · PromoterMichael C. Kauffman · NEEDHAM, MAExec · DirectorJeff Ginsberg · Boca Raton, FLExec · Director · PromoterGerald R. Royce · Cincinnati, OHExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗